Stimulation of Phosphatidylinositol 3-Kinase by Fibroblast Growth Factor Receptors Is Mediated by Coordinated Recruitment of Multiple Docking Proteins

Total Page:16

File Type:pdf, Size:1020Kb

Stimulation of Phosphatidylinositol 3-Kinase by Fibroblast Growth Factor Receptors Is Mediated by Coordinated Recruitment of Multiple Docking Proteins Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins S. H. Ong*, Y. R. Hadari†, N. Gotoh†, G. R. Guy*, J. Schlessinger†‡, and I. Lax† †Department of Pharmacology and The Skirball Institute, New York University, Medical School, New York, NY 10016; and *Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609 Contributed by J. Schlessinger, March 7, 2001 The docking protein FRS2 is a major downstream effector that links cific docking proteins such as IRS1 and Gab1, respectively fibroblast growth factor (FGF) and nerve growth factor receptors (19–22). In EGF signaling, PI3-kinase is recruited by hetero- with the Ras͞mitogen-activated protein kinase signaling cascade. oligomerization with ErbB3 and by tyrosine phosphorylation of In this report, we demonstrate that FRS2 also plays a pivotal role Gab1; a docking protein that upon tyrosine phosphorylation in FGF-induced recruitment and activation of phosphatidylinositol recruits and activates PI3-kinase (18, 21, 23). Moreover, PI3- 3-kinase (PI3-kinase). We demonstrate that tyrosine phosphoryla- kinase activity recruited through Gab1 was shown to be essential tion of FRS2␣ leads to Grb2-mediated complex formation with the for NGF-induced protection from apoptosis induced by serum docking protein Gab1 and its tyrosine phosphorylation, resulting in deprivation, as well as for neurite outgrowth in PC12 cells the recruitment and activation of PI3-kinase. Furthermore, Grb2 (24–26). Gab1 was originally cloned as a Grb2-associated protein bound to tyrosine-phosphorylated FRS2 through its SH2 domain that is tyrosine phosphorylated in cells upon stimulation with interacts primarily via its carboxyl-terminal SH3 domain with a EGF or insulin (20). Gab1 possesses an N-terminal pleckstrin proline-rich region in Gab1 and via its amino-terminal SH3 domain homology (PH) domain, a Met-binding domain (MBD) that with the nucleotide exchange factor Sos1. Assembly of mediates interactions with the Met receptor and other receptor FRS2␣:Grb2:Gab1 complex induced by FGF stimulation results in tyrosine kinases, and a large C-terminal portion containing activation of PI3-kinase and downstream effector proteins such as multiple tyrosine residues (20, 27). Tyrosine-phosphorylated the S͞T kinase Akt, whose cellular localization and activity are Gab1 is capable of recruiting several SH2 domain-containing regulated by products of PI3-kinase. These experiments reveal a signaling molecules including Grb2, Shp2, PLC␥, Crk1, PI3- unique mechanism for generation of signal diversity by growth kinase, and Nck (20, 24, 28, 29). Recently, a highly homologous factor-induced coordinated assembly of a multidocking protein isoform of Gab1, termed Gab2, was isolated (30, 31). Unlike the complex that can activate the Ras͞mitogen-activated protein ki- broad expression pattern of Gab1, Gab2 is predominantly ex- nase cascade to induce cell proliferation and differentiation, and pressed in hematopoietic cells (30). Several reports have shown PI3-kinase to activate a mediator of a cell survival pathway. that the Gab family of docking proteins are involved in the activation of PI3-kinase in response to growth factors or cyto- ibroblast growth factors (FGFs) play key roles in diverse kines stimulation and by activation of the B cell antigen receptor Fcellular processes including mitogenesis, differentiation, mi- (20, 21, 24, 25, 27, 28, 30, 32–35). gration, and survival (reviewed in refs. 1 and 2). We have In this report, we show that in response to FGF stimulation, FRS2␣ and Gab1 associate indirectly via Grb2 resulting in recently identified a major downstream mediator of signaling tyrosine phosphorylation of Gab1 and activation of the PI3- through the activated FGF receptors (FGFRs), termed FRS2, kinase͞Akt survival pathway. These experiments reveal a mech- that was redesignated FRS2␣ when a highly homologous iso- anism for activation of multiple signaling pathways by coordi- form, FRS2␤, was identified (3, 4). The FRS2 proteins are nated assembly of docking proteins. targeted to the plasma membrane by myristylation at the N terminus and contain a phosphotyrosine-binding domain that Materials and Methods mediates direct interaction with FGF or nerve growth factor Antibodies. Antibodies for FGFR1, FRS2, Grb2, Shc, Sos1, and (NGF) receptors (4–8). The C-terminal region of FRS2 contains pTyr were previously described (3, 4, 36). Anti-Shp2 antibodies multiple tyrosine residues that are phosphorylated by activated were from Transduction Laboratories (Lexington, KY). Anti- FGF or NGF receptors, serving as recognition motifs for the Gab1 antibodies were from Upstate Biotechnology (Lake Placid, SH2 domains of Grb2 and Shp2 (3, 9). Recruitment of both Grb2 NY). Anti-Akt and anti-pS473-Akt antibodies were from New and Shp2 are required for FGF-mediated mitogen-activated England Biolabs. Anti-FLAG (M2) antibodies were from Sigma. protein kinase (MAPK) activation, proliferation of fibroblasts, and neuronal differentiation of PC12 cells (3, 9). Cell Lines. Swiss 3T3, NIH 3T3, 293, COS-1, SH-SY5Y, and Although FGFs and neurotrophins are strongly implicated in L6-FGFR1 cells were cultured in DMEM supplemented with cell survival, the intracellular signaling machinery and mecha- nisms involved are not clear (1, 10, 11). Numerous studies have provided evidence that the PI3-kinase͞Akt (or PKB) signaling Abbreviations: PI3-kinase, phosphatidylinositol 3-kinase; FGFR, fibroblast growth factor cascade activated by multiple growth factors and cytokines receptor; NGF, nerve growth factor; wt, wild type; MBD, Met-binding domain; PH, Pleck- results primarily in cell survival (12–14), as opposed to the strin homology; KD, kinase inactive mutant; MAPK, mitogen-activated protein kinase; ͞ PDGF, platelet-derived growth factor; EGF, epidermal growth factor; GST, glutathione Ras MAPK pathway, which mainly signals to control cell pro- S-transferase; SH2 and 3, Src homology 2 and 3; GDNF, glial-derived neurotrophic factor. liferation and differentiation (15, 16). Although some receptors ‡To whom reprint requests should be addressed. E-mail: [email protected]. such as the platelet-derived growth factor (PDGF) and ErbB3 The publication costs of this article were defrayed in part by page charge payment. This recruit PI3-kinase directly (17, 18), other receptors such as the article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. insulin and epidermal growth factor (EGF) receptors use spe- §1734 solely to indicate this fact. 6074–6079 ͉ PNAS ͉ May 22, 2001 ͉ vol. 98 ͉ no. 11 www.pnas.org͞cgi͞doi͞10.1073͞pnas.111114298 Downloaded by guest on September 24, 2021 10% FBS, 10 mM L-glutamine, and 100 ␮g each of penicillin and streptomycin͞ml, all from GIBCO͞BRL. PC12 cells were grown in DMEM supplemented with 10% FCS and 10% heat- inactivated horse serum (GIBCO͞BRL). Expression Constructs. The FGFR1 expression vectors for wild- type (wt) or kinase-inactive (KD) mutant were previously de- scribed (36). FRS2␣ vectors for wt or the 6F-FRS2␣ mutant were described in refs. 3 and 4. Mouse Gab1 cDNA was kindly provided by W. Birchmeier (Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany). Gab1 mutants consisting of the PH domain or the MBD or point mutations were generated by standard PCR and subcloning procedures. The Akt plasmid was from P. Cohen (University of Dundee, Dundee, U.K.). Transient transfection of cells was performed by using Lipofectamine (GIBCO͞BRL). Glutathione S-transferase (GST) fusion pro- teins of Grb2 (amino acids 1–217), Grb2-SH2 (amino acid 54–164), Grb2-N-SH3 (amino acid 1–68), Grb2-C-SH3 (amino acid 156–199), Gab1 (amino acids 1–695), and Gab1-MBD (amino acids 450–532) were expressed in Escherichia coli and purified with glutathione-conjugated agarose beads (Sigma) according to established procedures. Immunoprecipitations, Protein Binding Studies, and PI3-Kinase As- says. The protocols for immunoprecipitations, binding studies Fig. 1. Complex formation between Grb2 and Gab1 in FGF-stimulated cells. with GST fusion proteins and in vitro PI3-kinase assays were as (A) Quiescent Swiss 3T3 cells were unstimulated or stimulated with FGF1 and described previously (3, 4, 17). heparin (100 ng͞ml and 5 ␮g͞ml, respectively) for 10 min. Lysates were immunoprecipitated with anti-Grb2 antibodies and followed by SDS–PAGE Results and immunoblotting with anti-pTyr antibodies. (B) Swiss 3T3 cells were un- stimulated or stimulated with FGF1 and heparin (100 ng͞ml and 5 ␮g͞ml, In a survey of tyrosine phosphoproteins involved in FGF sig- respectively) for 10 min. Cell lysates were incubated with immobilized GST naling, we have identified proteins that coimmunoprecipitate fusion proteins of the N-terminal SH3, SH2, or C-terminal SH3 domains of Grb2. with Grb2 upon FGF stimulation. Lysates from FGF-stimulated Bound proteins were eluted and resolved by SDS–PAGE and then followed by Swiss 3T3 fibroblasts were subjected to immunoprecipitation immunoblotting with anti-pTyr (Upper) or anti-Gab1 antibodies (Lower). (C) with anti-Grb2 antibodies followed by SDS–PAGE and immu- Gab1 binds to the C-terminal SH3 domain of Grb2 through the MBD. 293 cells noblotting with anti-pTyr antibodies. FGF induced the associa- were transfected with the expression vector for Flag-tagged MBD of Gab1. tion of multiple tyrosine-phosphorylated proteins with Grb2 The lysates were incubated with immobilized GST fusion proteins of the SH2,
Recommended publications
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • Intersectin 1 Forms Complexes with SGIP1 and Reps1 in Clathrin-Coated
    Biochemical and Biophysical Research Communications 402 (2010) 408–413 Contents lists available at ScienceDirect Biochemical and Biophysical Research Communications journal homepage: www.elsevier.com/locate/ybbrc Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated pits ⇑ Oleksandr Dergai a, ,1, Olga Novokhatska a,1, Mykola Dergai a, Inessa Skrypkina a, Liudmyla Tsyba a, Jacques Moreau b, Alla Rynditch a a Department of Functional Genomics, Institute of Molecular Biology and Genetics, NASU, 150 Zabolotnogo Street, 03680 Kyiv, Ukraine b Molecular Mechanisms of Development, Jacques Monod Institute, Development and Neurobiology Program, UMR7592 CNRS – Paris Diderot University, 15 rue Hélène Brion, 75205 Paris Cedex 13, France article info abstract Article history: Intersectin 1 (ITSN1) is an evolutionarily conserved adaptor protein involved in clathrin-mediated endo- Received 7 October 2010 cytosis, cellular signaling and cytoskeleton rearrangement. ITSN1 gene is located on human chromosome Available online 12 October 2010 21 in Down syndrome critical region. Several studies confirmed role of ITSN1 in Down syndrome pheno- type. Here we report the identification of novel interconnections in the interaction network of this endo- Keywords: cytic adaptor. We show that the membrane-deforming protein SGIP1 (Src homology 3-domain growth Endocytosis factor receptor-bound 2-like (endophilin) interacting protein 1) and the signaling adaptor Reps1 (RalBP Adaptor proteins associated Eps15-homology domain protein) interact with ITSN1 in vivo. Both interactions are mediated Intersectin 1 by the SH3 domains of ITSN1 and proline-rich motifs of protein partners. Moreover complexes compris- Protein interactions SGIP1 ing SGIP1, Reps1 and ITSN1 have been identified. We also identified new interactions between SGIP1, Reps1 Reps1 and the BAR (Bin/amphiphysin/Rvs) domain-containing protein amphiphysin 1.
    [Show full text]
  • Domain Requires the Gab2 Pleckstrin Homology Negative Regulation Of
    Ligation of CD28 Stimulates the Formation of a Multimeric Signaling Complex Involving Grb-2-Associated Binder 2 (Gab2), Src Homology Phosphatase-2, and This information is current as Phosphatidylinositol 3-Kinase: Evidence That of October 1, 2021. Negative Regulation of CD28 Signaling Requires the Gab2 Pleckstrin Homology Domain Richard V. Parry, Gillian C. Whittaker, Martin Sims, Downloaded from Christine E. Edmead, Melanie J. Welham and Stephen G. Ward J Immunol 2006; 176:594-602; ; doi: 10.4049/jimmunol.176.1.594 http://www.jimmunol.org/content/176/1/594 http://www.jimmunol.org/ References This article cites 59 articles, 38 of which you can access for free at: http://www.jimmunol.org/content/176/1/594.full#ref-list-1 Why The JI? Submit online. by guest on October 1, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Ligation of CD28 Stimulates the Formation of a Multimeric Signaling Complex Involving Grb-2-Associated Binder 2 (Gab2), Src Homology Phosphatase-2, and Phosphatidylinositol 3-Kinase: Evidence That Negative Regulation of CD28 Signaling Requires the Gab2 Pleckstrin Homology Domain1 Richard V.
    [Show full text]
  • Effects and Mechanisms of Eps8 on the Biological Behaviour of Malignant Tumours (Review)
    824 ONCOLOGY REPORTS 45: 824-834, 2021 Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review) KAILI LUO1, LEI ZHANG2, YUAN LIAO1, HONGYU ZHOU1, HONGYING YANG2, MIN LUO1 and CHEN QING1 1School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500; 2Department of Gynecology, Yunnan Tumor Hospital and The Third Affiliated Hospital of Kunming Medical University; Kunming, Yunnan 650118, P.R. China Received August 29, 2020; Accepted December 9, 2020 DOI: 10.3892/or.2021.7927 Abstract. Epidermal growth factor receptor pathway substrate 8 1. Introduction (Eps8) was initially identified as the substrate for the kinase activity of EGFR, improving the responsiveness of EGF, which Malignant tumours are uncontrolled cell proliferation diseases is involved in cell mitosis, differentiation and other physiological caused by oncogenes and ultimately lead to organ and body functions. Numerous studies over the last decade have demon- dysfunction (1). In recent decades, great progress has been strated that Eps8 is overexpressed in most ubiquitous malignant made in the study of genes and signalling pathways in tumours and subsequently binds with its receptor to activate tumorigenesis. Eps8 was identified by Fazioli et al in NIH-3T3 multiple signalling pathways. Eps8 not only participates in the murine fibroblasts via an approach that allows direct cloning regulation of malignant phenotypes, such as tumour proliferation, of intracellular substrates for receptor tyrosine kinases (RTKs) invasion, metastasis and drug resistance, but is also related to that was designed to study the EGFR signalling pathway. Eps8 the clinicopathological characteristics and prognosis of patients.
    [Show full text]
  • Time Resolved Quantitative Phosphoproteomics Reveals Distinct Patterns of SHP2
    bioRxiv preprint doi: https://doi.org/10.1101/598664; this version posted April 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Time resolved quantitative phosphoproteomics reveals distinct patterns of SHP2 dependence in EGFR signaling Vidyasiri Vemulapalli1,2, Lily Chylek3, Alison Erickson4, Jonathan LaRochelle1,2, Kartik Subramanian3, Morvarid Mohseni5, Matthew LaMarche5, Michael G. Acker5, Peter K. Sorger3, Steven P. Gygi4, and Stephen C. Blacklow1,2* 1Department of Cancer Biology, Dana-Farber Cancer Institute Boston, MA 02115, USA 2Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA 3Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA 4Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA 5Novartis Institutes for Biomedical Research, Cambridge, MA, 02139, USA *To whom correspondence should be addressed: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/598664; this version posted April 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract SHP2 is a protein tyrosine phosphatase that normally potentiates intracellular signaling by growth factors, antigen receptors, and some cytokines; it is frequently mutated in childhood leukemias and other cancers. Here, we examine the role of SHP2 in the responses of breast cancer cells to EGF by monitoring phosphoproteome dynamics when SHP2 is allosterically inhibited by the small molecule SHP099.
    [Show full text]
  • Noonan Syndrome and Related Disorders Sos1, Raf1, Kras & Shoc2 Gene Sequencing
    Molecular Diagnostic Laboratory 1600 Rockland Road, Wilmington, DE 19803 302.651.6775 email: [email protected] NOONAN SYNDROME AND RELATED DISORDERS SOS1, RAF1, KRAS & SHOC2 GENE SEQUENCING Noonan syndrome (OMIM 163950) is an autosomal dominant disorder due to mutations in several genes that are involved in the Ras-mitogen-activated protein kinase (RAS/MapK) pathway. Specifically, Noonan syndrome is caused by mutations in PTPN11* (OMIM 176876), SOS1 (OMIM 182530), RAF1 (OMIM 164760), and KRAS (OMIM 190070). Noonan syndrome is characterized by heart defects including hypertrophic cardiomyopathy and pulmonic valve stenosis, facial dysmorphology, short stature, chest wall deformities, and developmental delay. Noonan syndrome-like disorder with loose anagen hair (OMIM 607721) is a closely related disorder characterized by the above features as well as actively growing hair that is sparse, easy to pluck, thin, and slow-growing. This related disorder is due to mutations in SHOC2 (OMIM 602775), which is also involved in the RAS/MapK pathway. PTPN11* and RAF1 are also associated with LEOPARD syndrome (OMIM 151100). LEOPARD syndrome is an acronym for multiple lentigines, electrocardiogram abnormalities, ocular hypertelorism, pulmonic valvular stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness. LEOPARD syndrome is an autosomal dominant disorder, and can present much like Noonan syndrome with additional features. * Please note: We are no longer able to offer diagnostic testing for the PTPN11 gene due to patent restrictions enforced by U.S. Patent 7,335,469. Testing: Testing can be performed in tiers, moving to the next tier only if the preceding test is negative. Testing can also be performed concurrently or in any order requested.
    [Show full text]
  • Intersectin-1S Deficiency in Pulmonary Pathogenesis Niranjan Jeganathan1*, Dan Predescu2 and Sanda Predescu3
    Jeganathan et al. Respiratory Research (2017) 18:168 DOI 10.1186/s12931-017-0652-4 REVIEW Open Access Intersectin-1s deficiency in pulmonary pathogenesis Niranjan Jeganathan1*, Dan Predescu2 and Sanda Predescu3 Abstract Intersectin-1s (ITSN-1s), a multidomain adaptor protein, plays a vital role in endocytosis, cytoskeleton rearrangement and cell signaling. Recent studies have demonstrated that deficiency of ITSN-1s is a crucial early event in pulmonary pathogenesis. In lung cancer, ITSN-1s deficiency impairs Eps8 ubiquitination and favors Eps8-mSos1 interaction which activates Rac1 leading to enhanced lung cancer cell proliferation, migration and metastasis. Restoring ITSN-1s deficiency in lung cancer cells facilitates cytoskeleton changes favoring mesenchymal to epithelial transformation and impairs lung cancer progression. ITSN-1s deficiency in acute lung injury leads to impaired endocytosis which leads to ubiquitination and degradation of growth factor receptors such as Alk5. This deficiency is counterbalanced by microparticles which, via paracrine effects, transfer Alk5/TGFβRII complex to non-apoptotic cells. In the presence of ITSN-1s deficiency, Alk5-restored cells signal via Erk1/2 MAPK pathway leading to restoration and repair of lung architecture. In inflammatory conditions such as pulmonary artery hypertension, ITSN-1s full length protein is cleaved by granzyme B into EHITSN and SH3A-EITSN fragments. The EHITSN fragment leads to pulmonary cell proliferation via activation of p38 MAPK and Elk-1/c-Fos signaling. In vivo, ITSN-1s deficient mice transduced with EHITSN plasmid develop pulmonary vascular obliteration and plexiform lesions consistent with pathological findings seen in severe pulmonary arterial hypertension. These novel findings have significantly contributed to understanding the mechanisms and pathogenesis involved in pulmonary pathology.
    [Show full text]
  • Digital Gene Expression Profiling of Primary Acute Lymphoblastic
    Leukemia (2012) 26, 1218 --1227 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu ORIGINAL ARTICLE Digital gene expression profiling of primary acute lymphoblastic leukemia cells J Nordlund1, A Kiialainen1,9, O Karlberg1, EC Berglund1,HGo¨ ransson-Kultima2, M Sønderkær3, KL Nielsen3, MG Gustafsson2, M Behrendtz4, E Forestier5, M Perkkio¨ 6,SSo¨ derha¨ll7,GLo¨ nnerholm8 and A-C Syva¨nen1 We determined the genome-wide digital gene expression (DGE) profiles of primary acute lymphoblastic leukemia (ALL) cells from 21 patients taking advantage of ‘second-generation’ sequencing technology. Patients included in this study represent four cytogenetically distinct subtypes of B-cell precursor (BCP) ALL and T-cell lineage ALL (T-ALL). The robustness of DGE combined with supervised classification by nearest shrunken centroids (NSC) was validated experimentally and by comparison with published expression data for large sets of ALL samples. Genes that were differentially expressed between BCP ALL subtypes were enriched to distinct signaling pathways with dic(9;20) enriched to TP53 signaling, t(9;22) to interferon signaling, as well as high hyperdiploidy and t(12;21) to apoptosis signaling. We also observed antisense tags expressed from the non-coding strand of B50% of annotated genes, many of which were expressed in a subtype-specific pattern. Antisense tags from 17 gene regions unambiguously discriminated between the BCP ALL and T-ALL subtypes, and antisense tags from 76 gene regions discriminated between the 4 BCP subtypes. We observed a significant overlap of gene regions with alternative polyadenylation and antisense transcription (Po1 Â 10À15). Our study using DGE profiling provided new insights into the RNA expression patterns in ALL cells.
    [Show full text]
  • PTPN11, SOS1, KRAS, and RAF1 Gene Analysis, and Genotype–Phenotype Correlation in Korean Patients with Noonan Syndrome
    J Hum Genet (2008) 53:999–1006 DOI 10.1007/s10038-008-0343-6 ORIGINAL ARTICLE PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome Jung Min Ko Æ Jae-Min Kim Æ Gu-Hwan Kim Æ Han-Wook Yoo Received: 30 July 2008 / Accepted: 27 October 2008 / Published online: 20 November 2008 Ó The Japan Society of Human Genetics and Springer 2008 Abstract After 2006, germline mutations in the KRAS, KRAS (1.7%), and RAF1 (5.1%) genes. Three novel SOS1, and RAF1 genes were reported to cause Noonan mutations (T59A in PTPN11, K170E in SOS1, S259T in syndrome (NS), in addition to the PTPN11 gene, and now RAF1) were identified. The patients with PTPN11 muta- we can find the etiology of disease in approximately tions showed higher prevalences of patent ductus 60–70% of NS cases. The aim of this study was to assess arteriosus and thrombocytopenia. The patients with SOS1 the correlation between phenotype and genotype by mutations had a lower prevalence of delayed psychomotor molecular analysis of the PTPN11, SOS1, KRAS, and development. All patients with RAF1 mutations had RAF1 genes in 59 Korean patients with NS. We found hypertrophic cardiomyopathy. Typical facial features and disease-causing mutations in 30 (50.8%) patients, which auxological parameters were, on statistical analysis, not were located in the PTPN11 (27.1%), SOS1 (16.9%), significantly different between the groups. The molecular defects of NS are genetically heterogeneous and involve several genes other than PTPN11 related to the RAS- MAPK pathway. Electronic supplementary material The online version of this article (doi:10.1007/s10038-008-0343-6) contains supplementary material, which is available to authorized users.
    [Show full text]
  • Author's Personal Copy
    Author's personal copy Provided for non-commercial research and educational use only. Not for reproduction, distribution or commercial use. This article was originally published in the book Encyclopedia of Immunobiology, published by Elsevier, and the attached copy is provided by Elsevier for the author's benefit and for the benefit of the author's institution, for non-commercial research and educational use including without limitation use in instruction at your institution, sending it to specific colleagues who you know, and providing a copy to your institution's administrator. All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are prohibited. For exceptions, permission may be sought for such use through Elsevier’s permissions site at: http://www.elsevier.com/locate/permissionusematerial From Myers, D.R., Roose, J.P., 2016. Kinase and Phosphatase Effector Pathways in T Cells. In: Ratcliffe, M.J.H. (Editor in Chief), Encyclopedia of Immunobiology, Vol. 3, pp. 25–37. Oxford: Academic Press. Copyright © 2016 Elsevier Ltd. unless otherwise stated. All rights reserved. Academic Press Author's personal copy Kinase and Phosphatase Effector Pathways in T Cells Darienne R Myers and Jeroen P Roose, University of California, San Francisco (UCSF), San Francisco, CA, USA Ó 2016 Elsevier Ltd. All rights reserved. Abstract Multiple interconnected effector pathways mediate the activation of T cells following recognition of cognate antigen. These kinase and phosphatase pathways link proximal T cell receptor (TCR) signaling to changes in gene expression and cell physiology.
    [Show full text]
  • The Proto-Oncogene C-Cbl Is a Positive Regulator of Met-Induced MAP Kinase Activation: a Role for the Adaptor Protein Crk
    Oncogene (2000) 19, 4058 ± 4065 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc SHORT REPORT The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk Miguel Garcia-Guzman1, Elise Larsen1 and Kristiina Vuori*,1 1Cancer Research Center, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California, CA 92037, USA Hepatocyte growth factor triggers a complex biological (Cooper et al., 1984; Park et al., 1986; Rodrigues and program leading to invasive cell growth by activating the Park, 1993). c-Met receptor tyrosine kinase. Following activation, The cytoplasmic domain of Met contains two Met signaling is elicited via its interactions with SH2- autophosphorylation tyrosine residues, tyrosines 1349 containing proteins, or via the phosphorylation of the and 1356, which form a multi-substrate binding site for docking protein Gab1, and the subsequent interaction of several SH2-domain-containing cytoplasmic eectors Gab1 with additional SH2-containing eector molecules. and are thought to be crucial for Met-induced We have previously shown that the interaction between biological signaling (Ponzetto et al., 1994; Weidner et phosphorylated Gab1 and the adaptor protein Crk al., 1995; Zhu et al., 1994). In addition to the mediates activation of the JNK pathway downstream numerous SH2-containing molecules, the 110-kDa of Met. We report here that c-Cbl, which is a Gab1-like docking protein Gab1 also interacts with the activated docking protein, also becomes tyrosine-phosphorylated in Met receptor, either directly or indirectly via the response to Met activation and serves as a docking adaptor protein Grb2 (Fixman et al., 1997; Nguyen molecule for various SH2-containing molecules, includ- et al., 1997; Weidner et al., 1996).
    [Show full text]
  • Allostery Mediates Ligand Binding to Grb2 Adaptor in a Mutually Exclusive Manner Caleb B
    Research Article Received: 20 August 2012, Revised: 01 October 2012, Accepted: 12 November 2012, Published online in Wiley Online Library: 2012 (wileyonlinelibrary.com) DOI: 10.1002/jmr.2256 Allostery mediates ligand binding to Grb2 adaptor in a mutually exclusive manner Caleb B. McDonald, Jimmy El Hokayem, Nawal Zafar, Jordan E. Balke, Vikas Bhat, David C. Mikles, Brian J. Deegan, Kenneth L. Seldeen and Amjad Farooq* Allostery plays a key role in dictating the stoichiometry and thermodynamics of multi-protein complexes driving a plethora of cellular processes central to health and disease. Herein, using various biophysical tools, we demonstrate that although Sos1 nucleotide exchange factor and Gab1 docking protein recognize two non-overlapping sites within the Grb2 adaptor, allostery promotes the formation of two distinct pools of Grb2–Sos1 and Grb2–Gab1 binary signaling complexes in concert in lieu of a composite Sos1–Grb2–Gab1 ternary complex. Of particular interest is the observation that the binding of Sos1 to the nSH3 domain within Grb2 sterically blocks the binding of Gab1 to the cSH3 domain and vice versa in a mutually exclusive manner. Importantly, the formation of both the Grb2–Sos1 and Grb2–Gab1 binary complexes is governed by a stoichiometry of 2:1, whereby the respective SH3 domains within Grb2 homodimer bind to Sos1 and Gab1 via multivalent interactions. Collectively, our study sheds new light on the role of allostery in mediating cellular signaling machinery. Copyright © 2013 John Wiley & Sons, Ltd. Keywords: Multivalent
    [Show full text]